A forerunner in human lipid disorder research
Dyslipidemia, or elevated levels of blood fats such as cholesterol and triglycerides (lipids), can increase the risk of heart attacks, strokes, and other serious health issues. Robert Hegele, MD, is a world leader in the clinical management and research of lipid disorders, which represent a significant and often undertreated public health problem. His career integrates cutting-edge science with real-world applications grounded in patient care. A Distinguished University Professor of Medicine and Biochemistry at Western University and Director of the London Regional Genomics Centre at Robarts Research Institute, Dr. Hegele has discovered genetic causes for several rare conditions, including hepatic lipase deficiency and familial partial lipodystrophy types 2 and 3. In addition to his innovative research, Dr. Hegele has been instrumental in translating this research into practical diagnostic platforms and therapies that directly benefit patients. Notably, he helped to develop LipidSeq, a next-generation DNA sequencing panel that has become a standard of care for thousands of patients in Ontario. Dr. Hegele has transformed our understanding and management of genetic dyslipidemias, a contribution reflected in over 1,000 peer-reviewed publications and numerous prestigious awards.
About the CMHF
The Canadian Medical Hall of Fame (CMHF) celebrates Canadian heroes whose work advances health in Canada and the world, fostering future generations of health professionals through the delivery of local and national youth education programs and awards.
This enduring tribute to our country’s rich medical history is showcased here and in our physical exhibit hall in London, ON
